Algorithm accelerated: machine-learning may reduce drug formulation development times
![](/46/pdcnewsitem/11/97/22/CPHI%20images%20(10).png)
Machine-learning models demonstrate the potential to accelerate drug formulation discovery and development for long-acting injectables.
Scientists at the University of Toronto Leslie Dan Faculty of Pharmacy have tested and demonstrated the successful use of machine-learning models to aid in the design of long-acting injectable drug formulations. The research has potential to accelerate drug development times and reduce costs.
Long-acting injectables encompass advanced drug delivery systems that release the therapeutic component of the drug over long periods of time, allowing for a prolonged therapeutic effect. Such injectables can increase patient adherence and increase therapeutic efficacy by injecting close to the site of action. A reduction of side effects has also been reported. These advantages have positioned long-acting injectables as one of the most promising modes of administration for chronic diseases. However, one of the challenges associated with long-term injectables involves achieving the optimal amount of drug released over a specified period, requiring drug formulation candidates to be developed, characterised, and authorised through extensive experiments. As a result, bottlenecks within the development of these therapeutics have increased more than other types of drug formulations.
Professor in pharmaceutical sciences at the University of Toronto Christine Allen commented that “This study takes a critical step towards data-drive drug formulation development with an emphasis on long-acting injectables. We’ve seen how machine-learning has enabled incredible leap-step advances in the discovery of new molecules that have the potential to become medicines. We are now working to apply the same techniques to help us design better drug formulations and, ultimately, better medicines.”
The team at the University of Toronto trained and evaluated 11 different models of machine-learning tools to accurately predict the rate of drug release. These models included multiple linear regression, random forest, and light gradient boosting machine, among others. Results provided by the models’ test set were compared with previous experimental data, with tree-based models delivering the most accurate results. Further analysis of the data sets were able to extract drug design criteria from the machine-learning models. In particular, the light gradient boosting machine-learning model was utilised to design a long-acting injectable formulation for an ovarian cancer drug currently available. The drug resulting drug release rate was further tested and validated by the light gradient boosting machine model. The formulation produced the slow-release rate sought after by the researchers. Pauric Bannigan, a research associate at the University of Toronto, stated: “This [is] significant because in the past it might have taken us several iterations to get to a release profile that looked like this. With machine-learning, we got there in one.”
While challenges remain for the complete usage of machine-learning to reduce reliance on trial-and-error testing for the development of long-acting injectables, mainly due to the lack of open-source data available for pharmaceutical sciences, the team hope to work towards this development of robust databases in pharmaceuticals. “For this study, our goal was to lower the barrier of entry to applying machine-learning in pharmaceutical sciences...We’ve made our data sets fully available so others can hopefully build on this work. We want this to be the start of something and not the end of the story for machine-learning in drug formulation,” Bannigan stated.
Source: University of Toronto scientists use machine | EurekAlert!
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance